S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
S&P 500   4,273.53 (-1.47%)
DOW   33,618.88 (-1.14%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)

Chemours (CC) Stock Forecast, Price & News

$28.62
-1.12 (-3.77%)
(As of 09/26/2023 ET)
Compare
Today's Range
$28.15
$29.49
50-Day Range
$29.75
$38.61
52-Week Range
$23.58
$39.05
Volume
2.32 million shs
Average Volume
1.25 million shs
Market Capitalization
$4.24 billion
P/E Ratio
N/A
Dividend Yield
3.49%
Price Target
$38.22

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.10 Rating Score
Upside/​Downside
33.6% Upside
$38.22 Price Target
Short Interest
Healthy
3.31% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.16mentions of Chemours in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
20.12%
From $3.38 to $4.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Basic Materials Sector

49th out of 161 stocks

Chemicals & Allied Products Industry

8th out of 15 stocks


CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Price History

CC Stock News Headlines

U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Chemours Company (CC) Receives a Hold from RBC Capital
F-Gases: A Critical Link to Decarbonization
BMO Capital Keeps Their Buy Rating on Chemours Company (CC)
Barclays Keeps Their Hold Rating on Chemours Company (CC)
BMO Capital Sticks to Their Buy Rating for Chemours Company (CC)
Q2 2023 Chemours Co Earnings Call
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Last Earnings
7/28/2023
Ex-Dividend for 9/15 Dividend
8/14/2023
Dividend Payable
9/15/2023
Today
9/26/2023
Next Earnings (Estimated)
10/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$38.22
High Stock Price Forecast
$53.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+34.0%
Consensus Rating
Hold
Rating Score (0-4)
2.10
Research Coverage
10 Analysts

Profitability

Net Income
$578 million
Pretax Margin
-0.48%

Debt

Sales & Book Value

Annual Sales
$6.79 billion
Cash Flow
$6.51 per share
Book Value
$7.34 per share

Miscellaneous

Free Float
145,663,000
Market Cap
$4.22 billion
Optionable
Optionable
Beta
1.98
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Mark E. NewmanMr. Mark E. Newman (Age 60)
    CEO, Pres & Director
    Comp: $2.17M
  • Mr. David C. Shelton Esq.Mr. David C. Shelton Esq. (Age 59)
    Legal Advisor
    Comp: $845.64k
  • Ms. Denise M. DignamMs. Denise M. Dignam (Age 57)
    Pres of Titanium Technologies
    Comp: $977.06k
  • Mr. Jonathan S. Lock (Age 42)
    Section 16 Officer, Sr. VP & CFO
  • Ms. Camela T. Wisel (Age 48)
    VP, Chief Accounting Officer & Controller
  • Mr. Brandon Ontjes
    VP of FP&A and Investor Relations
  • Ms. Kristine M. Wellman (Age 54)
    Sr. VP, Gen. Counsel & Company Sec.
  • Ms. Alvenia ScarboroughMs. Alvenia Scarborough (Age 49)
    Sr. VP of Corp. Communications & Chief Brand Officer
  • Ms. Susan M. Kelliher (Age 56)
    Sr. VP of People
  • Mr. Matthew S. AbbottMr. Matthew S. Abbott (Age 46)
    Sr. VP & Chief Enterprise Transformation Officer













CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings
or view top-rated stocks.

What is Chemours' stock price forecast for 2023?

10 brokerages have issued 1 year price objectives for Chemours' shares. Their CC share price forecasts range from $25.00 to $53.00. On average, they expect the company's share price to reach $38.22 in the next twelve months. This suggests a possible upside of 34.0% from the stock's current price.
View analysts price targets for CC
or view top-rated stocks among Wall Street analysts.

How have CC shares performed in 2023?

Chemours' stock was trading at $30.62 at the beginning of 2023. Since then, CC shares have decreased by 6.9% and is now trading at $28.52.
View the best growth stocks for 2023 here
.

Are investors shorting Chemours?

Chemours saw a drop in short interest in the month of August. As of August 31st, there was short interest totaling 4,840,000 shares, a drop of 10.4% from the August 15th total of 5,400,000 shares. Based on an average daily trading volume, of 1,390,000 shares, the days-to-cover ratio is currently 3.5 days. Currently, 3.3% of the shares of the company are sold short.
View Chemours' Short Interest
.

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
View our CC earnings forecast
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) announced its quarterly earnings results on Friday, July, 28th. The specialty chemicals company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $1.09 by $0.01. The specialty chemicals company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.75 billion. Chemours had a negative net margin of 1.40% and a positive trailing twelve-month return on equity of 46.14%. During the same quarter in the prior year, the business posted $1.89 EPS.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Wednesday, July 26th. Stockholders of record on Tuesday, August 15th will be paid a dividend of $0.25 per share on Friday, September 15th. This represents a $1.00 annualized dividend and a yield of 3.51%. The ex-dividend date of this dividend is Monday, August 14th.
Read our dividend analysis for CC
.

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.32%.
Read our dividend analysis for CC.

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY 2023 earnings guidance on Friday, July, 28th. The company provided EPS guidance of $3.27-$3.60 for the period, compared to the consensus earnings per share estimate of $4.02. The company issued revenue guidance of -.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.52%), Bank of New York Mellon Corp (3.77%), State Street Corp (2.95%), JPMorgan Chase & Co. (2.36%), LSV Asset Management (1.89%) and Dimensional Fund Advisors LP (1.71%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $28.52.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $4.22 billion and generates $6.79 billion in revenue each year. The specialty chemicals company earns $578 million in net income (profit) each year or ($0.68) on an earnings per share basis.

How many employees does Chemours have?

The company employs 6,600 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for the company is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -